Periods | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 3 Years | All Time |
---|---|---|---|---|---|---|---|
Primex-40 | |||||||
HDFC Ergo General Insurance Company Limited |
Particulars |
31ST March, 2023 |
31ST March, 2022 |
31ST March, 2021 |
SOURCES OF FUNDS |
|
|
|
SHARE CAPITAL |
71,27,800 |
71,27,800 |
71,15,649 |
SHARE APPLICATION |
8,769 |
— |
- |
RESERVES AND SURPLUS |
3,20,26,002 |
2,79,94,137 |
2,51,55,927 |
FAIR VALUE CHANGE ACCOUNT - SHAREHOLDERS |
56,360 |
1,32,032 |
46,834 |
FAIR VALUE CHANGE ACCOUNT - POLICYHOLDERS |
2,42,013 |
5,20,846 |
2,17,132 |
BORROWINGS |
82,90,000 |
52,90,000 |
50,40,000 |
DEFERRED TAX LIABILITY |
— |
— |
— |
TOTAL |
4,77,50,944 |
4,10,64,815 |
3,75,75,542 |
APPLICATION OF FUNDS |
|
|
|
INVESTMENTS - SHAREHOLDERS |
4,20,11,314 |
3,72,04,597 |
2,95,28,835 |
INVESTMENTS - POLICYHOLDERS |
18,04,04,772 |
14,67,65,923 |
13,69,00,703 |
LOANS |
— |
— |
— |
FIXED ASSETS |
36,40,987 |
29,92,962 |
27,33,604 |
DEFERRED TAX ASSET |
5,23,078 |
5,86,610 |
7,36,533 |
CURRENT ASSETS |
|
|
|
Cash and Bank Balances |
31,52,831 |
13,42,855 |
47,38,249 |
Advances and Other Assets |
2,09,20,783 |
2,40,11,507 |
1,85,51,807 |
Sub-Total (A) |
2,40,73,614 |
2,53,54,362 |
2,32,90,056 |
CURRENT LIABILITIES |
14,86,92,843 |
12,62,25,710 |
11,23,12,673 |
PROVISIONS |
5,42,09,978 |
4,56,13,929 |
4,33,01,516 |
Sub-Total (B) |
20,29,02,821 |
17,18,39,639 |
15,56,14,189 |
NET CURRENT ASSETS/(LIABILITIES) (C) = (A-B) |
-17,88,29,207 |
-14,64,85,277 |
-13,23,24,133 |
MISCELLANEOUS EXPENDITURE |
— |
|
— |
DEBIT BALANCE IN PROFIT AND LOSS ACCOUNT |
— |
— |
— |
TOTAL |
4,77,50,944 |
4,10,64,815 |
3,75,75,542 |
Particulars |
31ST March 2023 |
31ST March 2022 |
31ST March 2021 |
OPERATING PROFIT/(LOSS) |
|
|
|
Fire Insurance |
12,29,641 |
8,72,725 |
-2,54,704 |
Marine Insurance |
-9,76,202 |
-2,59,603 |
-2,07,186 |
Miscellaneous Insurance |
64,73,545 |
41,29,879 |
77,70,647 |
TOTAL |
67,26,984 |
47,43,001 |
73,08,757 |
INCOME FROM INVESTMENTS |
|
|
|
Interest, Dividend and Rent – Gross |
25,33,855 |
20,89,248 |
16,61,112 |
Profit on sale of investments |
1,95,684 |
3,51,153 |
1,99,059 |
Less: Loss on sale of investments |
-8,765 |
-3,490 |
— |
TOTAL |
27,20,774 |
24,36,911 |
18,60,171 |
OTHER INCOME |
— |
— |
|
TOTAL (A) |
94,47,758 |
71,79,912 |
91,68,928 |
PROVISIONS (OTHER THAN TAXATION) |
— |
— |
— |
For diminution in the value of investments |
-1,74,669 |
-2,96,751 |
3,11,725 |
For doubtful debts |
2,22,536 |
-1,183 |
-11,816 |
TOTAL |
47,867 |
-2,97,934 |
2,99,909 |
OTHER EXPENSES |
|
|
|
Expenses other than those related to insurance business |
— |
— |
93,124 |
Employees’ related remuneration and welfare benefits |
1,20,325 |
1,12,483 |
— |
Corporate Social Responsibility Expenses |
1,26,636 |
1,13,876 |
95,202 |
Bad debts written off |
18,661 |
18,126 |
21,212 |
Remuneration to directors and others |
7,015 |
4,170 |
4,120 |
Bad & Doubtful Investments written off (Refer note 10 of Schedule 16) |
— |
1,33,400 |
— |
Amalgamation Expenses |
— |
— |
328426 |
Interest on Debentures |
4,33,202 |
4,09,148 |
4,09,243 |
Debenture issuance expenses |
9,598 |
8,948 |
— |
TOTAL (B) |
7,63,304 |
5,02,217 |
12,51,236 |
PROFIT/(LOSS) BEFORE TAX |
86,84,454 |
66,77,695 |
79,17,692 |
Provision for Taxation |
— |
— |
— |
Current Tax |
20,94,328 |
15,26,455 |
20,11,440 |
Deferred Tax |
63,531 |
1,49,924 |
-10,258 |
PROFIT/(LOSS) AFTER TAX |
65,26,595 |
50,01,316 |
59,16,510 |
APPROPRIATIONS |
|
|
|
Interim Dividends paid during the year |
24,94,730 |
23,16,535 |
21,34,695 |
Proposed final Dividend |
— |
— |
— |
Transfer to any Reserves or Other Accounts |
— |
— |
— |
Dividend Distribution tax |
— |
— |
— |
Transfer to any Reserves or Other Accounts |
— |
— |
— |
Transfer to Debenture Redemption Reserve |
— |
— |
— |
Transfer to Contingency Reserve for Unexpired Risks |
— |
— |
— |
Balance of Profit/(Loss) brought forward from previous year |
1,04,68,714 |
77,83,933 |
40,02,118 |
BALANCE CARRIED FORWARD TO BALANCE SHEET |
1,45,00,579 |
1,04,68,714 |
77,83,933 |
EARNINGS PER SHARE (Basic) |
9.16 |
7.02 |
8.32 |
EARNINGS PER SHARE (Diluted) |
9.13 |
7 |
8.29 |
Particulars Schedule |
March 31, 2023 |
March 31, 2022 |
March 31, 2021 |
Cash flows from operating activities |
|
|
|
Premium received from policyholders, including advance receipts |
19,66,28,477 |
15,15,02,343 |
14,60,28,961 |
Payments to re-insurers, net of commission and claims |
-2,33,76,300 |
-2,28,08,999 |
-2,33,65,657 |
Payments to co-insurers, net of claims recovery |
3,37,644 |
6,23,568 |
5,16,553 |
Payments of claims |
-9,11,44,196 |
-8,27,09,792 |
-6,33,83,344 |
Payments of commission and brokerage |
-1,57,93,812 |
-1,28,18,928 |
-1,18,06,102 |
Payments of other operating expenses |
-2,62,08,371 |
-1,97,56,326 |
-2,10,16,226 |
Corporate Social Responsibility (CSR) expenses |
-1,26,636 |
-1,13,876 |
-95,202 |
Deposits, advances and staff loans |
-3,22,455 |
1,39,022 |
77,143 |
Income taxes paid (Net) |
-18,69,785 |
-15,61,635 |
-21,06,753 |
Goods and Services Tax paid |
-97,97,054 |
-83,35,878 |
-62,17,673 |
Net cash generated from/(used in) operating activities (A) |
2,83,27,512 |
41,59,499 |
1,86,31,700 |
Cash flows from investing activities |
|
|
|
Purchase of fixed assets |
-13,44,298 |
-7,98,634 |
-6,11,530 |
Proceeds from sale of fixed assets |
22,902 |
12,621 |
41,000 |
Purchase of investments |
-1,03,59,62,940 |
-12,59,42,910 |
-7,46,65,676 |
Sale of investments |
98,67,48,329 |
10,29,71,221 |
4,96,17,718 |
Rent/Interest/Dividend received |
1,45,73,865 |
1,23,81,513 |
1,14,28,407 |
Investments in money market instruments and in liquid mutual funds (Net) |
93,94,778 |
61,50,646 |
-50,33,544 |
Net cash flow from/(used in) investing activities (B) |
-2,65,67,364 |
-52,25,543 |
-1,92,23,625 |
Cash flows from financing activities |
|
|
|
Proceeds from issuance of share capital and share premium |
— |
1,65,580 |
57,738 |
Receipt of Share application money pending allotment |
8,769 |
— |
— |
Repayments of borrowing |
-8,00,000 |
-35,00,000 |
— |
Proceeds from issuance of borrowing |
38,00,000 |
37,50,000 |
— |
Interest Paid |
-4,35,589 |
-4,08,905 |
-4,06,645 |
Dividend paid (Including dividend distribution tax) |
-24,94,730 |
-23,16,535 |
-21,34,695 |
Net cash flow from/(used in) financing activities (C) |
78,450 |
-23,09,860 |
-24,83,602 |
Effect of foreign exchange rates on cash and cash equivalents (Net) (D) |
-1,571 |
-6,152 |
-1,028 |
Net increase/(decrease) in cash and cash equivalents |
18,37,027 |
-33,82,056 |
-30,76,555 |
Cash and cash equivalents at the beginning of the year |
13,05,453 |
46,87,509 |
77,64,064 |
Cash and cash equivalents at the end of the period |
31,42,480 |
13,05,453 |
46,87,509 |
Net increase/(decrease) in cash and cash equivalents |
18,37,027 |
-33,82,056 |
-30,76,555 |
Reconciliation of Cash and cash equivalents with the Balance Sheet: |
|
|
|
Cash and Bank balances |
3152831 |
1342855 |
47,38,249 |
Less: Deposit Accounts not considered as Cash and cash equivalents as defined in AS-3 |
-10,351 |
-37,402 |
-50,740 |
Cash and cash equivalents at the end of the period |
31,42,480 |
13,05,453 |
46,87,509 |
Operating Activities:
The operating activities section provides insights into the company 's core business cash flows. In this case, the company received a significant amount of premium from policyholders, showing a healthy inflow from its insurance business. Payments to re-insurers, co-insurers, and claims highlight the company 's engagement with other entities in the insurance sector. Additionally, payments for commissions, operating expenses, and taxes represent the day-to-day operational costs. The positive net cash generated from operating activities indicates that the company 's core business is bringing in more cash than it is spending.
Investing Activities:
The investing activities section outlines the company 's capital expenditures and investment-related cash flows. Notably, the company made substantial investments in fixed assets, investments, and money market instruments. The proceeds from the sale of investments and the receipt of rent, interest, and dividends indicate returns on the company 's investment portfolio. The overall negative net cash flow from investing activities suggests that the company is making significant investments in its operations and portfolio.
Financing Activities:
Financing activities represent the cash flows associated with the company 's capital structure. In this case, the company did not raise funds through the issuance of share capital and share premium during the period. However, it received share application money pending allotment and made repayments of borrowings. The company also raised capital through the issuance of borrowings. Interest paid and dividends distributed represent the financial costs associated with the company 's capital. The small positive net cash flow from financing activities suggests a relatively stable financing structure during the period.
Net Cash Position:
The net increase in cash and cash equivalents is determined by summing the net cash flows from operating, investing, and financing activities. In this scenario, there is a notable increase in cash and cash equivalents, indicating that the company generated more cash than it spent during the period. The cash and cash equivalents at the end of the period are reconciled with the balance sheet, providing a clear picture of the company 's liquidity. The positive net cash position indicates that the company is in a healthy financial position, with sufficient cash to meet its short-term obligations and potentially invest in growth opportunities.
Particulars |
31ST March, 2023 |
31ST March, 2022 |
31ST March, 2021 |
SOURCES OF FUNDS |
|
|
|
SHARE CAPITAL |
71,27,800 |
71,27,800 |
71,15,649 |
SHARE APPLICATION |
8,769 |
— |
- |
RESERVES AND SURPLUS |
3,20,26,002 |
2,79,94,137 |
2,51,55,927 |
FAIR VALUE CHANGE ACCOUNT - SHAREHOLDERS |
56,360 |
1,32,032 |
46,834 |
FAIR VALUE CHANGE ACCOUNT - POLICYHOLDERS |
2,42,013 |
5,20,846 |
2,17,132 |
BORROWINGS |
82,90,000 |
52,90,000 |
50,40,000 |
DEFERRED TAX LIABILITY |
— |
— |
— |
TOTAL |
4,77,50,944 |
4,10,64,815 |
3,75,75,542 |
APPLICATION OF FUNDS |
|
|
|
INVESTMENTS - SHAREHOLDERS |
4,20,11,314 |
3,72,04,597 |
2,95,28,835 |
INVESTMENTS - POLICYHOLDERS |
18,04,04,772 |
14,67,65,923 |
13,69,00,703 |
LOANS |
— |
— |
— |
FIXED ASSETS |
36,40,987 |
29,92,962 |
27,33,604 |
DEFERRED TAX ASSET |
5,23,078 |
5,86,610 |
7,36,533 |
CURRENT ASSETS |
|
|
|
Cash and Bank Balances |
31,52,831 |
13,42,855 |
47,38,249 |
Advances and Other Assets |
2,09,20,783 |
2,40,11,507 |
1,85,51,807 |
Sub-Total (A) |
2,40,73,614 |
2,53,54,362 |
2,32,90,056 |
CURRENT LIABILITIES |
14,86,92,843 |
12,62,25,710 |
11,23,12,673 |
PROVISIONS |
5,42,09,978 |
4,56,13,929 |
4,33,01,516 |
Sub-Total (B) |
20,29,02,821 |
17,18,39,639 |
15,56,14,189 |
NET CURRENT ASSETS/(LIABILITIES) (C) = (A-B) |
-17,88,29,207 |
-14,64,85,277 |
-13,23,24,133 |
MISCELLANEOUS EXPENDITURE |
— |
|
— |
DEBIT BALANCE IN PROFIT AND LOSS ACCOUNT |
— |
— |
— |
TOTAL |
4,77,50,944 |
4,10,64,815 |
3,75,75,542 |
Particulars |
31ST March 2023 |
31ST March 2022 |
31ST March 2021 |
OPERATING PROFIT/(LOSS) |
|
|
|
Fire Insurance |
12,29,641 |
8,72,725 |
-2,54,704 |
Marine Insurance |
-9,76,202 |
-2,59,603 |
-2,07,186 |
Miscellaneous Insurance |
64,73,545 |
41,29,879 |
77,70,647 |
TOTAL |
67,26,984 |
47,43,001 |
73,08,757 |
INCOME FROM INVESTMENTS |
|
|
|
Interest, Dividend and Rent – Gross |
25,33,855 |
20,89,248 |
16,61,112 |
Profit on sale of investments |
1,95,684 |
3,51,153 |
1,99,059 |
Less: Loss on sale of investments |
-8,765 |
-3,490 |
— |
TOTAL |
27,20,774 |
24,36,911 |
18,60,171 |
OTHER INCOME |
— |
— |
|
TOTAL (A) |
94,47,758 |
71,79,912 |
91,68,928 |
PROVISIONS (OTHER THAN TAXATION) |
— |
— |
— |
For diminution in the value of investments |
-1,74,669 |
-2,96,751 |
3,11,725 |
For doubtful debts |
2,22,536 |
-1,183 |
-11,816 |
TOTAL |
47,867 |
-2,97,934 |
2,99,909 |
OTHER EXPENSES |
|
|
|
Expenses other than those related to insurance business |
— |
— |
93,124 |
Employees’ related remuneration and welfare benefits |
1,20,325 |
1,12,483 |
— |
Corporate Social Responsibility Expenses |
1,26,636 |
1,13,876 |
95,202 |
Bad debts written off |
18,661 |
18,126 |
21,212 |
Remuneration to directors and others |
7,015 |
4,170 |
4,120 |
Bad & Doubtful Investments written off (Refer note 10 of Schedule 16) |
— |
1,33,400 |
— |
Amalgamation Expenses |
— |
— |
328426 |
Interest on Debentures |
4,33,202 |
4,09,148 |
4,09,243 |
Debenture issuance expenses |
9,598 |
8,948 |
— |
TOTAL (B) |
7,63,304 |
5,02,217 |
12,51,236 |
PROFIT/(LOSS) BEFORE TAX |
86,84,454 |
66,77,695 |
79,17,692 |
Provision for Taxation |
— |
— |
— |
Current Tax |
20,94,328 |
15,26,455 |
20,11,440 |
Deferred Tax |
63,531 |
1,49,924 |
-10,258 |
PROFIT/(LOSS) AFTER TAX |
65,26,595 |
50,01,316 |
59,16,510 |
APPROPRIATIONS |
|
|
|
Interim Dividends paid during the year |
24,94,730 |
23,16,535 |
21,34,695 |
Proposed final Dividend |
— |
— |
— |
Transfer to any Reserves or Other Accounts |
— |
— |
— |
Dividend Distribution tax |
— |
— |
— |
Transfer to any Reserves or Other Accounts |
— |
— |
— |
Transfer to Debenture Redemption Reserve |
— |
— |
— |
Transfer to Contingency Reserve for Unexpired Risks |
— |
— |
— |
Balance of Profit/(Loss) brought forward from previous year |
1,04,68,714 |
77,83,933 |
40,02,118 |
BALANCE CARRIED FORWARD TO BALANCE SHEET |
1,45,00,579 |
1,04,68,714 |
77,83,933 |
EARNINGS PER SHARE (Basic) |
9.16 |
7.02 |
8.32 |
EARNINGS PER SHARE (Diluted) |
9.13 |
7 |
8.29 |
Particulars Schedule |
March 31, 2023 |
March 31, 2022 |
March 31, 2021 |
Cash flows from operating activities |
|
|
|
Premium received from policyholders, including advance receipts |
19,66,28,477 |
15,15,02,343 |
14,60,28,961 |
Payments to re-insurers, net of commission and claims |
-2,33,76,300 |
-2,28,08,999 |
-2,33,65,657 |
Payments to co-insurers, net of claims recovery |
3,37,644 |
6,23,568 |
5,16,553 |
Payments of claims |
-9,11,44,196 |
-8,27,09,792 |
-6,33,83,344 |
Payments of commission and brokerage |
-1,57,93,812 |
-1,28,18,928 |
-1,18,06,102 |
Payments of other operating expenses |
-2,62,08,371 |
-1,97,56,326 |
-2,10,16,226 |
Corporate Social Responsibility (CSR) expenses |
-1,26,636 |
-1,13,876 |
-95,202 |
Deposits, advances and staff loans |
-3,22,455 |
1,39,022 |
77,143 |
Income taxes paid (Net) |
-18,69,785 |
-15,61,635 |
-21,06,753 |
Goods and Services Tax paid |
-97,97,054 |
-83,35,878 |
-62,17,673 |
Net cash generated from/(used in) operating activities (A) |
2,83,27,512 |
41,59,499 |
1,86,31,700 |
Cash flows from investing activities |
|
|
|
Purchase of fixed assets |
-13,44,298 |
-7,98,634 |
-6,11,530 |
Proceeds from sale of fixed assets |
22,902 |
12,621 |
41,000 |
Purchase of investments |
-1,03,59,62,940 |
-12,59,42,910 |
-7,46,65,676 |
Sale of investments |
98,67,48,329 |
10,29,71,221 |
4,96,17,718 |
Rent/Interest/Dividend received |
1,45,73,865 |
1,23,81,513 |
1,14,28,407 |
Investments in money market instruments and in liquid mutual funds (Net) |
93,94,778 |
61,50,646 |
-50,33,544 |
Net cash flow from/(used in) investing activities (B) |
-2,65,67,364 |
-52,25,543 |
-1,92,23,625 |
Cash flows from financing activities |
|
|
|
Proceeds from issuance of share capital and share premium |
— |
1,65,580 |
57,738 |
Receipt of Share application money pending allotment |
8,769 |
— |
— |
Repayments of borrowing |
-8,00,000 |
-35,00,000 |
— |
Proceeds from issuance of borrowing |
38,00,000 |
37,50,000 |
— |
Interest Paid |
-4,35,589 |
-4,08,905 |
-4,06,645 |
Dividend paid (Including dividend distribution tax) |
-24,94,730 |
-23,16,535 |
-21,34,695 |
Net cash flow from/(used in) financing activities (C) |
78,450 |
-23,09,860 |
-24,83,602 |
Effect of foreign exchange rates on cash and cash equivalents (Net) (D) |
-1,571 |
-6,152 |
-1,028 |
Net increase/(decrease) in cash and cash equivalents |
18,37,027 |
-33,82,056 |
-30,76,555 |
Cash and cash equivalents at the beginning of the year |
13,05,453 |
46,87,509 |
77,64,064 |
Cash and cash equivalents at the end of the period |
31,42,480 |
13,05,453 |
46,87,509 |
Net increase/(decrease) in cash and cash equivalents |
18,37,027 |
-33,82,056 |
-30,76,555 |
Reconciliation of Cash and cash equivalents with the Balance Sheet: |
|
|
|
Cash and Bank balances |
3152831 |
1342855 |
47,38,249 |
Less: Deposit Accounts not considered as Cash and cash equivalents as defined in AS-3 |
-10,351 |
-37,402 |
-50,740 |
Cash and cash equivalents at the end of the period |
31,42,480 |
13,05,453 |
46,87,509 |
Operating Activities:
The operating activities section provides insights into the company 's core business cash flows. In this case, the company received a significant amount of premium from policyholders, showing a healthy inflow from its insurance business. Payments to re-insurers, co-insurers, and claims highlight the company 's engagement with other entities in the insurance sector. Additionally, payments for commissions, operating expenses, and taxes represent the day-to-day operational costs. The positive net cash generated from operating activities indicates that the company 's core business is bringing in more cash than it is spending.
Investing Activities:
The investing activities section outlines the company 's capital expenditures and investment-related cash flows. Notably, the company made substantial investments in fixed assets, investments, and money market instruments. The proceeds from the sale of investments and the receipt of rent, interest, and dividends indicate returns on the company 's investment portfolio. The overall negative net cash flow from investing activities suggests that the company is making significant investments in its operations and portfolio.
Financing Activities:
Financing activities represent the cash flows associated with the company 's capital structure. In this case, the company did not raise funds through the issuance of share capital and share premium during the period. However, it received share application money pending allotment and made repayments of borrowings. The company also raised capital through the issuance of borrowings. Interest paid and dividends distributed represent the financial costs associated with the company 's capital. The small positive net cash flow from financing activities suggests a relatively stable financing structure during the period.
Net Cash Position:
The net increase in cash and cash equivalents is determined by summing the net cash flows from operating, investing, and financing activities. In this scenario, there is a notable increase in cash and cash equivalents, indicating that the company generated more cash than it spent during the period. The cash and cash equivalents at the end of the period are reconciled with the balance sheet, providing a clear picture of the company 's liquidity. The positive net cash position indicates that the company is in a healthy financial position, with sufficient cash to meet its short-term obligations and potentially invest in growth opportunities.
Particulars |
31 March 2022 |
31 March 2021 |
Current Ratio (in times) |
0.20 |
0.21 |
Net Commission Ratio |
-3.90% |
-3.05% |
Net Retention Ratio |
51.85% |
52.27% |
Gross direct premium to the net-worth ratio (in times) |
4.20 |
4.20 |
Net Incurred Claims to Net Earned Premium |
84.04% |
75.75% |
Combined Ratio |
107.48% |
103.25% |
Liquid Assets to liabilities ratio (in times) |
0.26 |
0.33 |
Available Solvency Margin (ASM) to Required Solvency Margin (RSM) Ratio (in times) |
1.64 |
1.90 |
Operating Profit Ratio |
6.90% |
11.41% |
Net Earnings Ratio |
7.04% |
9.10% |
Return on Net Worth Ratio |
15.57% |
20.21% |
The Above given financial ratios of HDFC Ergo for the year ended on March 31, 2022 and March 31, 2021, provide information about the company 's financial performance and its ability to meet its obligations. Here is a summary of each ratio:
Particulars |
2023 |
2022 |
2021 |
Dividend (final + interim) (In Rs.) |
3.5 |
3.25 |
3 |